
Is VUG a Good ETF to Buy?
For the last few years, earnings growth from the tech…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2017-03-31 | 2018-03-31 | 2019-03-31 | 2018-03-31 | 2019-03-31 | |
Income Statement | ||||||
Revenue | $1.2B | $1.4B | $1.3B | -- | -- | |
Gross Profit | $795.6M | $915.2M | $816.3M | -- | -- | |
Operating Income | $247.2M | $284.2M | $303.3M | -- | -- | |
EBITDA | $252.9M | $283.6M | $325M | -- | -- | |
Diluted EPS | $0.40 | $0.34 | $0.35 | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $2.1B | $2.2B | $2.1B | $2.7B | $2.6B | |
Total Assets | $3.1B | $3.3B | $3.1B | $3.8B | $3.8B | |
Current Liabilities | $733.8M | $974.5M | $998.5M | $1.1B | $992.1M | |
Total Liabilities | $1.4B | $1.4B | $1.4B | $1.9B | $1.6B | |
Total Equity | $1.7B | $1.8B | $1.7B | $1.9B | $2.1B | |
Total Debt | $584.1M | $444.6M | $413.9M | $882.2M | $736.7M |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2023-03-13 | 2024-03-13 | 2024-03-13 | |||
Cash Flow Statement | ||||||
Cash Flow Operations | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Free Cash Flow | -- | -- | -- | -- | -- |
Remy Cointreau is the world’s second-largest distiller of cognac by volume, with a 15.8% global volume share in 2022, according to Euromonitor. Cognac represented 72% of Remy's sales and 90% of EBIT in the same year. The remainder of Remy’s portfolio is made up of much smaller group-owned brands, including Cointreau orange liqueur, Metaxa Greek spirit, Mount Gay rum, Bruichladdich single malt scotch, The Botanist gin, Hautes Glaces French whiskey, and Westland American whiskey. The company also distributes third-party brands and, in 2023, entered the fragrance business. Remy is controlled by the Andromede family, which owns 41% equity interest and consolidates the business in the Andromede Group. The Cointreau family owns a further 27%, and 41% of the equity is free float.
In the current month, REMYY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The REMYY average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Remy Cointreau share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Remy Cointreau share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Remy Cointreau is a Sell and believe this share price will rise from its current level to --.
The price target for Remy Cointreau over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Remy Cointreau is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Remy Cointreau via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Remy Cointreau shares.
Remy Cointreau was last trading at $5.07 per share. This represents the most recent stock quote for Remy Cointreau. Yesterday, Remy Cointreau closed at $5.38 per share.
In order to purchase Remy Cointreau stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
For the last few years, earnings growth from the tech…
Intel Corporation (NASDAQ:INTC)’s recent innovations, Xeon 6 SoC and Xeon®…
For many years, Walmart (NYSE:WMT) has been the world’s largest…
Market Cap: $3.3T
P/E Ratio: 36x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.7T
P/E Ratio: 37x
Guardant Health [GH] is up 1.1% over the past day.
Teradyne [TER] is down 0.36% over the past day.
Limbach Holdings [LMB] is down 4.39% over the past day.